Invenio Imaging Completes Enrollment in Pivotal ON-SITE Study for NIO Lung Cancer Reveal

Shots: Invenio has completed patient enrollment in the ON-SITE study evaluating NIO Lung Cancer Reveal, an AI-based image analysis module for rapid assessment of bronchoscopic lung biopsy specimens imaged with the NIO Imaging System The study enrolled 1,006 pts, involving >3,250 fresh biopsy specimens across 7 US medical centers, with specimens collected using transbronchial forceps biopsy, cryobiopsy, transbronchial needle aspiration, & EBUS-guided transbronchial needle aspiration; data will support regulatory submission NIO Lung Cancer Reveal is an AI-powered tool that detects tissue morphology suspicious for lung cancer & assists physicians during bronchoscopy, with ON-SITE pivotal data being analyzed to support its regulatory submission Ref: PRnewswire   |  Image: Invenio Imaging   |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Invenio Imaging Completes Enrollment in Pivotal ON-SITE Study for NIO Lung Cancer Reveal appeared first on PharmaShots.